International Clinical Trial: Urinary Bladder Matrix (UBM) Registry

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07805798) titled 'Urinary Bladder Matrix (UBM) Registry' on Sept. 1.

Study Type: Observational [Patient Registry]

Primary Sponsor: Integra LifeSciences Corporation

Condition: Tissue Repair Soft Tissue Reconstruction Wound Management Pressure Ulcer (PU) Necrotizing Soft Tissue Infection Fournier's Gangrene Pilonidal Cyst Open Abdomen Hidradenitis Suppurativa (HS) Lower Extremity Wound Incisional

Intervention: Device: Urinary Bladder Matrix (UBM) Products

Recruitment Status: Not recruiting

Date of First Enrollment: August 31, 2026

Target Sample Size: 300

To know more, visit https://clinicaltrials.gov/study/NCT07805798

Discl...